Cardiac involvement in inflammatory myopathies and inherited muscle diseases

JB Lilleker, M Roberts… - Current opinion in …, 2020 - journals.lww.com
Cardiac involvement in inflammatory myopathies and inherited... : Current Opinion in
Rheumatology Cardiac involvement in inflammatory myopathies and inherited muscle …

[HTML][HTML] Is Cardiac Transplantation Still a Contraindication in Patients with Muscular Dystrophy-Related End-Stage Dilated Cardiomyopathy? A Systematic Review

L Politano - International Journal of Molecular Sciences, 2024 - mdpi.com
Inherited muscular diseases (MDs) are genetic degenerative disorders typically caused by
mutations in a single gene that affect striated muscle and result in progressive weakness …

MyomiRNAs and myostatin as physical rehabilitation biomarkers for myotonic dystrophy

V Pegoraro, P Cudia, A Baba, C Angelini - Neurological Sciences, 2020 - Springer
MiR-1 and myostatin are markers for muscle growth and regeneration. Myostatin has a key
role in the regulation of muscle mass. Myotonic dystrophy type 1 (DM1) patients have a …

[HTML][HTML] Myotonic dystrophy type 1 presenting with dyspnea: A case report

YX Jia, CL Dong, JW Xue, XQ Duan… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Myotonic dystrophy type 1 (DM1) is a genetic neuromuscular disease
involving multiple systems, especially the cardiopulmonary system. The clinical phenotype …

Outcome measures frequently used to assess muscle strength in patients with myotonic dystrophy type 1: a systematic review

T Mateus, A Costa, D Viegas, A Marques… - Neuromuscular …, 2022 - Elsevier
Measurement of muscle strength is fundamental for the management of patients with
myotonic dystrophy type 1 (DM1). Nevertheless, guidance on this topic is somewhat limited …

[HTML][HTML] Case Report: Severe Peripartum Cardiac Disease in Myotonic Dystrophy Type 1

G Besant, PR Bourque, IC Smith, S Chih… - Frontiers in …, 2022 - frontiersin.org
Background: Myotonic dystrophy type 1 (DM1) is a hereditary muscular dystrophy affecting~
2.1-14.3/100,000 adults. Cardiac manifestations of DM1 include conduction disorders and …

[HTML][HTML] 强直性肌营养不良1 型患者的临床特点及CTG 重复次数分析

董明睿, 叶伟杰, 刘尊敬, 孙青, 王丽… - Journal of International …, 2019 - html.rhhz.net
目的总结强直性肌营养不良1 型患者的临床, 神经电生理和遗传学特点. 方法收集3
例强直性肌营养不良1 型患者的临床症状, 肌电图, 肌肉病理及基因检测结果. 结果3 …

[HTML][HTML] Myotonic dystrophy

G Meola, R Cardani - in-chief. MedLink Neurology. San Diego …, 2011 - medlink.com
The myotonic dystrophies are a multisystem, autosomal dominantly inherited, highly variable
muscle disease more frequent in adults. So far two distinct entities have been described …

[HTML][HTML] Outcome of Myotonic Dystrophy 1 Depends on Comprehensive Diagnostic and Therapeutic Management

J Finsterer, RN Ciudin, NC Dragatoiu, S Sipos… - Maedica, 2020 - ncbi.nlm.nih.gov
We do not agree with the conclusion that MD1 patient should receive prophylactic
implantation of a paemkaer (1). MD1 patients may not only experience supra-ventricular but …

[PDF][PDF] A6 Cardiac, skeletal and respiratory methods and outcome measures of choice to evaluate muscle strength of patients with Myotonic Dystrophy Type 1: A …

T Mateus, A Costa, D Viegas, A Marques, MT Herdeiro… - 2020 - scholar.archive.org
Myotonic dystrophy type 1 (DM1) is the most common form of muscular dystrophy in adults
with a prevalence of 1 in 3,000 to 8,000 individuals worldwide [1, 2]. DM1 is an autosomal …